Spero Therapeutics: And In The Press Release Furnished As Exhibit 99.1 Hereto Shall Not Be Deemed Filed For Purposes Of Section 18 Of The Securities Exchange Act Of 1934, As Amended, Or Otherwise Subject To The Liabilities Of That Section Or Sections 11 And 12(a)(2) Of The Securities Act Of 1933, As Amended, Or Incorporated By Reference In Any Filing With The U.s. Securities And Exchange Commission Made By The Company, Whether Made Before Or After The Date Hereof, Regardless Of Any General Incorporation Language In Such Filing, Financial Statements And Exhibits

Show full article

This functionality is available for registred users only

• Full name
  Spero Therapeutics, Inc.
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***